Biblio

Export 155 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
S. A. Khmeleva, Radko, S. P., Kozin, S. A., Kiseleva, Y. Y., Mezentsev, Y. V., Mitkevich, V. A., Kurbatov, L. K., Ivanov, A. S., and Makarov, A. A., “Zinc-Mediated Binding of Nucleic Acids to Amyloid-β Aggregates: Role of Histidine Residues.”, J Alzheimers Dis, vol. 54, no. 2, pp. 809-19, 2016.
E. M. Khedr, Omeran, N., Ramadan, H. Karam- Alla, Ahmed, G. K., and Abdelwarith, A. M., “Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
W. Khan, Giampietro, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., Flor, H., Frouin, V., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Lemaître, H., Nees, F., Paus, T., Pausova, Z., Rietschel, M., Smolka, M. N., Ströhle, A., Gallinat, J., Vellas, B., Soininen, H., Kloszewska, I., Tsolaki, M., Mecocci, P., Spenger, C., Villemagne, V. L., Masters, C. L., Muehlboeck, J. - S., Bäckman, L., Fratiglioni, L., Kalpouzos, G., Wahlund, L. - O., Schumann, G., Lovestone, S., Williams, S. C. R., Westman, E., and Simmons, A., “A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
D. Singh Khalsa and Newberg, A. B., “Spiritual Fitness: A New Dimension in Alzheimer's Disease Prevention.”, J Alzheimers Dis, vol. 80, no. 2, pp. 505-519, 2021.
N. Ketter, H Brashear, R., Bogert, J., Di, J., Miaux, Y., Gass, A., Purcell, D. D., Barkhof, F., and H Arrighi, M., “Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 57, no. 2, pp. 557-573, 2017.
M. Kero, Raunio, A., Polvikoski, T., Tienari, P. J., Paetau, A., and Myllykangas, L., “Hippocampal Sclerosis in the Oldest Old: A Finnish Population-Based Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 263-272, 2018.
O. Keret, Shochat, T., Steiner, I., and Glik, A., “Non-Ashkenazi Jewish Origin is Associated with Early Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 3, pp. 877-884, 2018.
K. Planeta Kepp, “Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 447-457, 2017.
B. A. Kent, Strittmatter, S. M., and Nygaard, H. B., “Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1325-1336, 2018.
G. Kennedy, Hardman, R. J., Macpherson, H., Scholey, A. B., and Pipingas, A., “How Does Exercise Reduce the Rate of Age-Associated Cognitive Decline? A Review of Potential Mechanisms.”, J Alzheimers Dis, vol. 55, no. 1, pp. 1-18, 2017.
G. Kennedy, Meyer, D., Hardman, R. J., Macpherson, H., Scholey, A. B., and Pipingas, A., “Physical Fitness and Aortic Stiffness Explain the Reduced Cognitive Performance Associated with Increasing Age in Older People.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1307-1316, 2018.
R. E. Kennedy, Cutter, G. R., Wang, G., and Schneider, L. S., “Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1205-15, 2016.
D. Kempuraj, Selvakumar, G. Pushpavath, Thangavel, R., Ahmed, M. Ejaz, Zaheer, S., Kumar, K. Kuppamma, Yelam, A., Kaur, H., Dubova, I., Raikwar, S. P., Iyer, S. S., and Zaheer, A., “Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1117-1129, 2018.
N. Kemppainen, Joutsa, J., Johansson, J., Scheinin, N. M., Någren, K., Rokka, J., Parkkola, R., and Rinne, J. O., “Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 48, no. 1, pp. 123-33, 2015.
D. Kelly, Coen, R. F., Akuffo, K. Owusu, Beatty, S., Dennison, J., Moran, R., Stack, J., Howard, A. N., Mulcahy, R., and Nolan, J. M., “Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids.”, J Alzheimers Dis, vol. 48, no. 1, pp. 261-77, 2015.
A. Keleman, Wisch, J. K., Bollinger, R. M., Grant, E. A., Benzinger, T. L., Morris, J. C., Ances, B. M., and Stark, S. L., “Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 2, pp. 843-853, 2020.
P. Gavin Kehoe, “The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?”, J Alzheimers Dis, vol. 62, no. 3, pp. 1443-1466, 2018.
P. Gavin Kehoe, Hibbs, E., Palmer, L. E., and J Miners, S., “Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology.”, J Alzheimers Dis, vol. 58, no. 1, pp. 203-214, 2017.
P. G. Kehoe, Blair, P. S., Howden, B., Thomas, D. L., Malone, I. B., Horwood, J., Clement, C., Selman, L. E., Baber, H., Lane, A., Coulthard, E., Passmore, A. Peter, Fox, N. C., Wilkinson, I. B., and Ben-Shlomo, Y., “The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 803-814, 2018.
J. Thomas- Ric Keeney, Ibrahimi, S., and Zhao, L., “Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.”, J Alzheimers Dis, vol. 48, no. 2, pp. 411-24, 2015.
H. Kazui, Takahashi, R., Yamamoto, Y., Yoshiyama, K., Kanemoto, H., Suzuki, Y., Sato, S., Azuma, S., Suehiro, T., Shimosegawa, E., Ishii, K., and Tanaka, T., “Neural Basis of Apathy in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1403-1416, 2017.
T. Kawarabayashi, Nakamura, T., Sato, K., Seino, Y., Ichii, S., Nakahata, N., Takatama, M., Westaway, D., St George-Hyslop, P., and Shoji, M., “Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1189-1203, 2022.
S. Kawanishi, Takata, K., Itezono, S., Nagayama, H., Konoya, S., Chisaki, Y., Toda, Y., Nakata, S., Yano, Y., Kitamura, Y., and Ashihara, E., “Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 563-585, 2018.
K. Kawamura, Miyajima, M., Nakajima, M., Kanai, M., Motoi, Y., Nojiri, S., Akiba, C., Ogino, I., Xu, H., Kamohara, C., Yamada, S., Karagiozov, K., Ikeuchi, T., Kondo, A., and Arai, H., “Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 83, no. 1, pp. 179-190, 2021.
S. Bagewadi Kawalia, Raschka, T., Naz, M., Simoes, Rde Matos, Senger, P., and Hofmann-Apitius, M., “Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1237-1254, 2017.

Pages